24 May 2013
Keywords: IMS Health, MIDAS Biosimilars, Marketin measurement tool
Article | 22 August 2011
IMS Health has launched IMS MIDAS Biosimilars, a market measurement tool that enables clients to assess the value of treatments ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 August 2011
23 August 2011
23 May 2013
© 2013 thepharmaletter.com